Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $12.28 million. The enterprise value is $10.25 million.

Market Cap	12.28M
Enterprise Value	10.25M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026, after market close.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

AKTX has 1.14 million shares outstanding. The number of shares has increased by 143.97% in one year.

Current Share Class	n/a
Shares Outstanding	1.14M
Shares Change (YoY)	+143.97%
Shares Change (QoQ)	+37.44%
Owned by Insiders (%)	53.99%
Owned by Institutions (%)	5.91%
Float	416,604

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.27, with a Debt / Equity ratio of 0.05.

Current Ratio	0.27
Quick Ratio	0.21
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.77

Financial Efficiency

Return on equity (ROE) is -155.28% and return on invested capital (ROIC) is -39.40%.

Return on Equity (ROE)	-155.28%
Return on Assets (ROA)	-17.97%
Return on Invested Capital (ROIC)	-39.40%
Return on Capital Employed (ROCE)	-59.58%
Weighted Average Cost of Capital (WACC)	16.73%
Revenue Per Employee	n/a
Profits Per Employee	-$4.67M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.88% in the last 52 weeks. The beta is 1.33, so AKTX's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-76.88%
50-Day Moving Average	9.47
200-Day Moving Average	15.48
Relative Strength Index (RSI)	46.85
Average Volume (20 Days)	112,751

Short Selling Information

The latest short interest is 121,540, so 38.71% of the outstanding shares have been sold short.

Short Interest	121,540
Short Previous Month	64,685
Short % of Shares Out	38.71%
Short % of Float	n/a
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.20M
Pretax Income	-29.91M
Net Income	-28.05M
EBITDA	n/a
EBIT	-12.20M
Earnings Per Share (EPS)	-$26.91

Full Income Statement

Balance Sheet

The company has $2.77 million in cash and $732,000 in debt, giving a net cash position of $2.04 million or $1.78 per share.

Cash & Cash Equivalents	2.77M
Total Debt	732,000
Net Cash	2.04M
Net Cash Per Share	$1.78
Equity (Book Value)	14.38M
Book Value Per Share	12.56
Working Capital	-9.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.91M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	1.43M
Free Cash Flow	-10.91M
FCF Per Share	-$9.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-143.97%
Shareholder Yield	-143.97%
Earnings Yield	-228.38%
FCF Yield	-88.80%

Analyst Forecast

The average price target for AKTX is $26.78, which is 149.58% higher than the current price. The consensus rating is "Buy".

Price Target	$26.78
Price Target Difference	149.58%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:40.

Last Split Date	Mar 31, 2026
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	2